Advertisement

Dopaminrezeptoren und Schizophrenie: Bedeutung der D1- und D5-Rezeptoren

  • P. H. Andersen
Conference paper

Zusammenfassung

Vor über 40 Jahren entdeckten Delay et al. (Delay et al. 1952) die antipsychotischen Eigenschaften von Chlorpromazin. Zwar vermochte Chlorpromazin die Schizophrenie nicht zu heilen, doch war seine Entdeckung ein bedeutender Durchbruch in der Therapie dieser schweren Krankheit — die Gabe von Chlorpromazin verhindert bei schizophrenen Patienten einige der am stärksten beeinträchtigenden Symptome, wie z. B. Halluzinationen und Wahnvorstellungen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Andersen PH (1988) Comparison of the pharmacological characteristics of [3H]raclopride and [3H]-SCH-23390 binding to dopamine receptors in vivo in mouse brain. Eur J Pharmacol 146: 113–120PubMedCrossRefGoogle Scholar
  2. Andersen PH, Braestrup C (1986) Evidence for different states of the dopamine D1 receptor: clozapine and fluperlapine may preferentially label an adenylate cyclase coupled state of the DI receptor. J Neurochem 47: 1822PubMedCrossRefGoogle Scholar
  3. Andersen PH, Gronvald FC (1986) Specific binding of [3H]-SCH-23390 to dopamine D1 receptors in vivo. Life Sci 38: 1507–1515 (Published erratum appears in Life Sci 19:1117)Google Scholar
  4. Andersen PH, Gronvald FC, Aas Jansen J (1985) A comparison between dopamine stimulated adenylate cyclase and [3H]-SCH-23390 binding in rat striatum. Life Sci 37: 191CrossRefGoogle Scholar
  5. Andersen PH, Nielsen EB, Grynvald FC, Braestrup C (1986) Some atypical neuroleptics inhibit [3H]-SCH-23390 binding in vivo. Eur J Pharmacol 120: 143–144PubMedCrossRefGoogle Scholar
  6. Andersen PH, Gingrich JA, Bates MD, Dearry A, Falardeau P, Senogles SE, Caron MG (1990) Dopamine receptor subtypes: beyond the D1/D2 classification. TIPS 11: 231PubMedGoogle Scholar
  7. Andersen PH, Grlnvald FC, Hohlweg R, Hansen LB, Guddal E, Braestrup C, Nielsen EB (1992) NNC-112, NNC-687 and NNC-756, new selective and highly potent dopamine D1 receptor antagonists. Eur J Pharmacol 21: 45–52CrossRefGoogle Scholar
  8. Apud JA, Masotto C, Ongini E, Racagni G (1985) Interaction of SCH-23390, a D1 selective antagonist with the anterior pituitary D2 receptors and prolactin secretin in the rat. Eur J Pharmacol 112: 187–193PubMedCrossRefGoogle Scholar
  9. Bouvier C, Salon JA, Johnson RA, Civelli O (1993) Dopaminergic activity measured in D1- and D2-transfected fibroblasts by silicon-microphysiometry. J Recept Res 13: 559–571PubMedGoogle Scholar
  10. Boyson SJ, McGonigle DLP, Molinoff PB (1986) Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamime receptors in rat brain. J Neurosci 6: 3177–3188PubMedGoogle Scholar
  11. Carlsson A (1978) Does dopamine have a role in schizophrenia? Biol Psychiatry 13: 3–21PubMedGoogle Scholar
  12. Christensen AV, Amt J, Hyttel J, Larsen JJ, Svendsen O (1984) Pharmacological effect of a specific dopamine D1 antagonist SCH-23390 in comparison with neuroleptics. Life Sci 34: 1529–1540PubMedCrossRefGoogle Scholar
  13. Civelli O, Bunzow JR, Grandy DK (1993) Molecular diversity of the dopamine receptors. Annu Rev Pharmacol Toxicol 32: 281–307CrossRefGoogle Scholar
  14. Creese I, Burt DR, Snyder SH (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192: 481–483PubMedCrossRefGoogle Scholar
  15. Dawson TM, Gehlert DR, McCabe RT, Barnett A, Wamsley JK (1986) D-1 dopamine receptors in the rat brain: a quantitative autoradiographic analysis. J Neurosci 6: 2352–2365PubMedGoogle Scholar
  16. Dearry A, Gingrich JA, Falardeau P, Fremeau RT, Bates MD, Caron MG (1990) Molecular cloning and expression of the gene for a human D1 dopamine receptor. Nature 347: 72PubMedCrossRefGoogle Scholar
  17. Delay J, Deniker P, Harl J-M (1952) Traitment des etats d’excitation et d’agitation par une méthode médicamenteuse dérivée de l’hiberno-thérapie. Ann Med Psychol (Paris) 110: 267–273Google Scholar
  18. Farde L, Wiesel F-A, Hall H, Halldin C, Sedvall G (1988) Central D2-dopamine receptor occupancy in schizophenic patients treated with antipsychotic drugs. Arch Gen Psychiatry 145: 71Google Scholar
  19. Farde L, Wiesel F-A, Nordström A-L, Sedvall G (1989) D1- and D2-dopamine receptor occupancy during treatment with conventional and atypcial neuroleptics. Psychopharmacology 99: 28CrossRefGoogle Scholar
  20. Fremeau RJ jr, Duncan GE, Fornaretto M-G et al. (1991) Localization of D1 dopamine receptor mRNA in brain support: a role in cognitive, affective and neuroendocrine aspects of dopaminergic transmission. Proc Natl Acad Sci USA 88: 3772–3776PubMedCrossRefGoogle Scholar
  21. Grandy DK, Zhang Y, Bouvier C et al. (1991) Multiple human D5 dopamine receptor genes: a functional receptor and two pseudo genes. Proc Natl Acad Sci USA 88: 9175PubMedCrossRefGoogle Scholar
  22. Hyttel J (1978) Effects of neuroleptics on [3H]-Haloperidol binding and [3I]-flupenticol binding and on adenylate cyclase in vitro. Life Sci 23: 551–556PubMedCrossRefGoogle Scholar
  23. Hyttel J (1983) SCH-23390–The first selective D1 antagonist. Eur J Pharmacol 91: 153–154PubMedCrossRefGoogle Scholar
  24. Iorio LC, Barnett A, Leits FH, Houser VP, Korduba CA (1983) SCH-23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. J Pharmacol Exp Ther 226: 462–268PubMedGoogle Scholar
  25. Kebabian JW, Caine DB (1979) Multiple receptors for dopamine. Nature 277: 93PubMedCrossRefGoogle Scholar
  26. Mahan LC, Burch RM, Monsma FJ, Sibley DR (1990) Expression of strital D1 dopamine receptors coupled to inositol phosphate production and calcium mobilization in Xenopus oocytes. Proc Natl Acad Sci USA 87: 2196PubMedCrossRefGoogle Scholar
  27. Meador-Woodruff JH, Mansour A, Grandy DK, Damask SP, Civelli O, Watson SJ jr (1992) Distribution of D5 dopamine receptor mRNA in rat brain. Neurosci Lett 145: 209–212PubMedCrossRefGoogle Scholar
  28. Meltzer HY (1988) New insights into schizophrenia through atypcial antipsychotic drugs. Neurophsychopharmacology 1: 193–196CrossRefGoogle Scholar
  29. Morelli M, Di Chiara G (1985) Catalepsy induced by SCH-23390 in rats. Eur J Pharmacol 117: 179PubMedCrossRefGoogle Scholar
  30. Nielsen EB, Andersen PH (1992) Dopamine receptor occupancy in vivo: behavioral correlates using NNC-112, NNC-687 and NNC-756, new selective dopamine D1 receptor antagonists. Eur J Pharmacol 219: 35–44PubMedCrossRefGoogle Scholar
  31. Nielsen EB, Jepsen SA (1985) Antagonism of the amphetamine cue by both classical and atypical antipsychotic drugs. Eur J Pharmacol 111: 167PubMedCrossRefGoogle Scholar
  32. O’Dowd BF (1993) Structures of dopamine receptors. J Neurochem 60: 804–816PubMedCrossRefGoogle Scholar
  33. Pedersen UB, Norby B, Jensen AA et al. (1995) Characteristics of stably expressed human D1a and 13 lb receptors: atypical behavior of the D1b receptor. Eur J Pharmacol (in press)Google Scholar
  34. Seeman P, Lee T, Chan-Wong M, Wong K (1976) Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261: 717–719PubMedCrossRefGoogle Scholar
  35. Sunahara, RK, Niznik HB, Weiner DM et al. (1990a) Human dopamine D1 receptor encoded by an intronless gene on chromosome 5. Nature 347: 80PubMedCrossRefGoogle Scholar
  36. Sunahara RK, Guan H-C, O’Dowd BF et al. (1990b) Cloning of a gene for a human dopamine D5 receptor with higher affinity for dopamine than Di. Nature 350: 614CrossRefGoogle Scholar
  37. Tiberi M, Jarvie KR, Silvia C et al. (1991) Cloning, molecular characterization and chromosomal assignment of a gene encoding a second Di dopamine receptor subtype: differential expression pattern in rat brain compared with the Dia receptor. Proc Natl Acad Sci USA 88: 7491PubMedCrossRefGoogle Scholar
  38. Undie AS, Friedman E (1990) Stimulation of a D1 receptor enhances inositol phosphates formation in rat brain. J Pharmacol Exp Ther 253: 987PubMedGoogle Scholar
  39. Weiner DM, Levey AI, Sunahara RK, Niznik HB, O’Dowd BF, Seeman P, Brann MR (1991) D1 and D2 dopamine receptor mRNA in rat brain. Proc Natl Acad Sci USA 88: 1859PubMedCrossRefGoogle Scholar
  40. Weinshank RL, Adham N, Macchi M, Olsen MA, Branchek TA, Hartig PR (1991) Molecular cloning and characterization of a high affinity dopamine receptor (D1O) and its pseudogene. J Biol Chem 266: 22427PubMedGoogle Scholar
  41. Zhou Q-Y, Grandy DK, Thambi L et al. (1990) Cloning and expression of human and rat D1 dopamine receptors. Nature 347: 76PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • P. H. Andersen

There are no affiliations available

Personalised recommendations